INTERFERON-FREE THERAPY OF CHRONIC HEPATITIS C LOWERS THE LONG-TERM RISK FOR DE NOVO HEPATOCELLULAR CARCINOMA IN PATIENTS WITH LIVER CIRRHOSIS

被引：0
|
作者：
Mettke, Friederike [1 ]
Deterding, Katja [1 ,2 ]
Port, Kerstin [1 ]
Schlevogt, Bernhard [3 ]
Manns, Michael P. [1 ,4 ,5 ]
Maasoumy, Benjamin [1 ]
Cornberg, Markus [1 ]
Wedemeyer, Heiner [2 ,4 ,6 ]
机构：
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[2] Essen Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany
[3] Univ Hosp Muenster, Dept Med Gastroenterol & Hepatol B, Munster, Germany
[4] Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany
[5] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany
[6] German Ctr Infect Res DZIF, Hannover, Germany
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1542
引用
收藏
页码：928A / 929A
页数：2
相关论文
共 50 条
  • [21] Risk assessment of hepatocellular carcinoma in chronic hepatitis B patients with long-term antiviral therapy
    Chung, Kyu Sik
    Kim, Do Young
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Ku, Hye Jin
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    HEPATOLOGY, 2015, 62 : 385A - 385A
  • [22] Long-term prospective study of antiviral therapy on reduced development of hepatocellular carcinoma in chronic Hepatitis C patients with cirrhosis.
    Shiratori, Y
    Ito, Y
    Yokosuka, O
    Imazeki, F
    Nakata, R
    Tanaka, N
    Arakawa, Y
    Katamoto, T
    Unuma, T
    Hirota, K
    Takano, S
    Hirano, M
    Kawase, T
    Hashimoto, E
    Yoshida, H
    Ohashi, Y
    Omata, M
    HEPATOLOGY, 2002, 36 (04) : 356A - 356A
  • [23] Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C
    Omata, M
    Shiratori, Y
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 : E134 - E140
  • [24] Impact of sustained virological response to interferon therapy for chronic hepatitis C on recurrence and long-term survival in patients with hepatocellular carcinoma
    Shinkawa, H.
    Hasegawa, K.
    Arita, J.
    Akamatsu, N.
    Kaneko, J.
    Sakamoto, Y.
    Kokudo, N.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S443 - S444
  • [25] Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients
    Ueda, Yoshihide
    Uemoto, Shinji
    TRANSPLANTATION, 2016, 100 (01) : 54 - 60
  • [26] Perspectives and challenges of interferon-free therapy for chronic hepatitis C
    Lange, Christian M.
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 583 - 592
  • [27] Long-Term Assessment of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients With Sustained Viral Response to Antiviral Therapy
    Wang, Chun-Hsiang
    Chang, Kuo-Kwen
    GASTROENTEROLOGY, 2012, 142 (05) : S958 - S958
  • [28] Long-term prognosis of type C chronic hepatitis patients treated with interferon; Development of hepatocellular carcinoma.
    Iijima, A
    Sodeyama, T
    Inada, H
    Ichijo, T
    Kobayashi, M
    Yamada, S
    Imai, H
    Yoshizawa, K
    Tanaka, E
    Kiyosawa, K
    HEPATOLOGY, 1997, 26 (04) : 1599 - 1599
  • [29] Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy
    Shindo, M
    Ken, A
    Okuno, T
    CANCER, 1999, 85 (09) : 1943 - 1950
  • [30] A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C-Associated Liver Cirrhosis
    Aleman, Soo
    Rahbin, Nogol
    Weiland, Ola
    Davidsdottir, Loa
    Hedenstierna, Magnus
    Rose, Nina
    Verbaan, Hans
    Stal, Per
    Carlsson, Tony
    Norrgren, Hans
    Ekbom, Anders
    Granath, Fredrik
    Hultcrantz, Rolf
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) : 230 - 236
12345